Veru to report fiscal 2023 third quarter financial results on august 10, 2023

Miami, fl, aug. 03, 2023 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing novel medicines for breast cancer and for viral acute respiratory distress syndrome (ards), today announced it will host a conference call and audio webcast on thursday, august 10, 2023, at 8:00 a.m. et to discuss its fiscal 2023 third quarter financial results and to provide a business update.
VERU Ratings Summary
VERU Quant Ranking